Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PDE6D | O43924 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8910757 | 0.95 | ESR1 (0.59) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL1306747 | 0.90 | ESR1 (0.69) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL7095574 | 0.90 | ESR1 (0.68) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| Hydrochloric Acid SCHEMBL10366282 | 0.88 | ESR1 (0.67) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL9255222 | 0.84 | ALDH1A1 (0.47) | ESR1TSHRCA12CA1CA2 | |
| SCHEMBL462619 | 0.83 | ESR1 (0.60) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL2399585 | 0.83 | ESR1 (0.60) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL28039002 | 0.83 | ESR1 (0.64) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL27850097 | 0.82 | ESR1 (0.58) | ESR1CYP3A4CYP2C19CYP2C9HIF1A | |
| SCHEMBL3833947 | 0.82 | ESR1 (0.59) | ESR1CYP3A4CYP2C19CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181377-A | Cyclotriphosphazene-based flame-retardant imidazole curing agent and preparation method and application thereof | 常州百思通复合材料有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-110016123-B | Heat-resistant flame-retardant epoxy resin latent curing agent | 广东固研电子材料有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-110016123-A | A kind of heat-resisting flame-retardant epoxy resin lalent solidifying agent | 广州市固研电子材料有限公司 | 2019-07-16 | — | — | CN | claimed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | claimed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | claimed |
| US-7479527-B2 | Polyepoxide and reaction product of aminoalkylimidazole, polyamine, urea and diepoxide as curing component | FUJI KASEI KOGYO CO., LTD. (JP) | 2009-01-20 | — | — | US | claimed |
| EP-1971600-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK Holdings Co., Ltd. (KR) | 2008-09-24 | — | — | EP | claimed |
| US-20080033116-A1 | One-Component Heat Curable Epoxide Composition | FUJI KASEI KOGYO, CO., LTD. (JP) | 2008-02-07 | — | — | US | claimed |
| WO-2007078113-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK HOLDINGS CO., LTD. (KR) | 2007-07-12 | — | — | WO | claimed |
| EP-4747320-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4526365-A1 | ACRYLATE-EPOXY RESIN COMPOSITIONS | Lyondellbasell Composites LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025015542-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-01-23 | — | — | WO | disclosed |
| US-20240327582-A1 | RAPID CURING EPOXY-RESIN COMPOSITION FOR FIBER-MATRIX SEMIFINISHED PRODUCTS | POLYNT COMPOSITES NORWAY AS (NO) | 2024-10-03 | — | — | US | disclosed |
| US-4555519-A | Thromboxane synthetase enzyme inhibiting N-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides | AMERICAN CYANAMID COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4489089-A | INHIBITION OF THE ENZYME THROMBOXANE SYNTHETASE | AMERICAN CYANAMID COMPANY (US) | 1984-12-18 | — | — | US | disclosed |
| EP-0127727-A2 | Substituted N-(omega-(1H-imidazol-1-yl)alkyl)) amides | AMERICAN CYANAMID COMPANY (US) | 1984-12-12 | — | — | EP | disclosed |
| EP-0117462-A2 | N-(2-4-(1H-imidazol-1-yl)alkyl)arylamides | AMERICAN CYANAMID COMPANY (US) | 1984-09-05 | — | — | EP | disclosed |
| US-3987230-A | GLASS FIBERS, EPOXY RESINS, PHENOLIC RESINS, PRINTED CIRCUITS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JA) | 1976-10-19 | — | — | US | disclosed |
| US-3962184-A | PROCESS FOR PREPARING CURED RESIN FROM CYANIC ACID ESTERS USING IMIDAZOLE CATALYSTS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JA) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | WNT3A, WNT1, WNT3 | ESR1 1683/4885CYP3A4 192/4885CYP2C19 1078/4885 |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | MAT1A, MAT2B, MAT2A | ESR1 1693/4885CYP3A4 3827/4885CYP2C19 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.